Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers

NCT03030105 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: BPN14770
DRUG: BPN14770 placebo
DRUG: Donepezil
DRUG: Donepezil placebo
DRUG: Scopolamine 0.6 MG/ML
DRUG: Scopolamine placebo

Sponsor

Tetra Discovery Partners